Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Income Stories

2014-03-05 08:21:10

- Navistar reports net loss of $248 million on revenues of $2.2 billion LISLE, Ill., March 5, 2014 /PRNewswire/ -- Navistar International Corporation (NYSE: NAV) today announced a first quarter 2014 net loss of $248 million, or $3.05 per diluted share, compared to a first quarter 2013 net loss of $123 million, or $1.53 per diluted share. Revenues in the quarter were $2.2 billion, down from $2.6 billion in the first quarter of 2013. Lower sales volumes, primarily due to the...

2014-03-04 23:23:31

Learn the 3-step process to flipping properties across the country at http://www.10hourwholesaler.com/presentation/. Flagler Beach, FL (PRWEB) March 04, 2014 Now it’s possible to wholesale properties across the country without leaving home via Private Money Blueprint’s “10-Hour Wholesaler,” real-estate investment training program at http://www.10hourwholesaler.com/presentation/. After discovering ways to cut down the time, costs and efforts involved in wholesaling properties, real...

2014-03-04 16:29:09

PORT WASHINGTON, N.Y., March 4, 2014 /PRNewswire/ -- Systemax Inc. (NYSE: SYX) today announced financial results for the fourth quarter and full year ended December 31, 2013. Performance Summary (U.S. dollars in millions, except per share data)...

2014-03-04 16:25:36

-- Company completes transition year and lays foundation for profitable growth; -- Quarterly revenues of $10.0 million declined primarily due to the timing of shipments; -- Net loss in the fourth quarter was $21.6 million, or $0.42 per diluted share, including R&D charges and one-time relocation expenses; -- Fourth quarter new order bookings of $11.4 million resulted in an ending...

2014-03-04 16:25:30

- 2014 Priorities: Complete and Report Top-line Results of First Pacritinib Phase 3 and Drive EU Sales of PIXUVRI - SEATTLE, March 4, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the fourth quarter and full year ended December 31, 2013. "2013 was a transformational year for CTI, as we entered into a worldwide license agreement with Baxter International to develop and commercialize our JAK2/FLT3 inhibitor, pacritinib, achieved...

2014-03-04 08:24:01

COLUMBUS, Ohio, March 4, 2014 /PRNewswire/ -- Oxford Resource Partners, LP (NYSE: OXF) (the "Partnership" or "Oxford") today announced fourth quarter and full year 2013 financial results. Fourth Quarter 2013 Results Adjusted EBITDA(([1])) was $8.2 million for the fourth quarter of 2013 compared to $8.0 million for the fourth quarter of 2012. The increase was driven by a 14.6 percent increase in cash margin to $6.61 per ton for the fourth quarter of 2013 from $5.77 per ton for the fourth...

2014-03-03 20:21:01

DARTMOUTH, N.S., March 3, 2014 /CNW/ - Newfoundland Capital Corporation Limited ("Company") today announces its financial results for the fourth quarter ending December 31, 2013. Highlights -- Revenue in the fourth quarter of $35.6 million improved by 2% or $0.6 million and for the year ended December 31, 2013, revenue of $132.6 million was 3% or $3.3 million higher than 2012. This improvement came from a combination of organic...

2014-03-03 20:20:34

TORONTO, March 3, 2014 /PRNewswire/ - AuRico Gold Inc. (TSX: AUQ) (NYSE: AUQ), ("AuRico" or the "Company") reports financial results for the three and twelve months ended December 31, 2013. The Company will host a conference call on Tuesday, March 4, 2014 beginning at 8:30 a.m. Eastern Time (details below). (All amounts are in U.S. dollars, unless otherwise indicated) Financial Highlights For the fourth quarter, the Company reported the following results: --...

2014-03-03 16:31:52

4Q13 Total Net Revenues Up 117.3% YOY to US$651.0 Million GUANGZHOU, China, March 3, 2014 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), China's leading online discount retailer for brands ("Vipshop" or the "Company") today announced its unaudited financial results for the quarter and full year ended December 31, 2013. Fourth Quarter 2013 Highlights -- Total net revenues increased by 117.3% over the prior year period to US$651.0 million, primarily attributable to a...

2014-03-03 16:26:20

SHENZHEN, China, March 3, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 -- Full year net revenues increased 14.5% year-over-year to $1.2 billion; excluding tax benefits, full year non-GAAP net income...